U.S. Senate candidate Greg Orman once sued actress Debbie Reynolds over a $1 million loan he made to her Hollywood memorabilia museum that had gone unpaid.
Orman brought the suit against the “Singin’ in the Rain” star in 2008. The suit names Reynolds, her son Todd Fisher and the Hollywood Motion Picture and Television Museum as defendants.
Reynolds was nominated for an Oscar for best actress in 1964 for her role as a survivor of the Titanic shipwreck in the “The Unsinkable Molly Brown.”
Orman loaned the museum $1 million in 2002, according to court documents.
Never miss a local story.
The museum, which housed Reynolds’ vast memorabilia collection, filed for Chapter 11 bankruptcy in 2009.
The case bounced from Johnson County court to federal court and back again before ultimately being dismissed in 2010.
A spokesman for Orman said that the parties settled the case out of court.
"Greg had a prior relationship with Debbie Reynolds and her son, Todd Fisher. Five years after making what was supposed to be a one-year loan, Greg sued to get repaid,” Sam Edelen, Orman’s spokesman, said in an e-mail.
“Greg ultimately negotiated a settlement with the parties and was repaid. Todd Fisher is supportive of Greg and recently contributed $1,000 to his campaign for U.S. Senate,” Edelen said.
Fisher, a film and television producer, is the brother of Carrie Fisher, known for her iconic role as Princess Leia in the “Star Wars” film franchise. Todd Fisher says that he has known Orman for 20 years and that Kansas would be lucky to have him representing it.
“We did get into litigation with Greg however this was done strictly as a business decision. In the end he and I have always settled our issues in person amicably, we remain friends to this day,” Fisher said in an e-mail. “…I feel Washington and Kansas would be lucky to have someone as qualified as Greg representing (the) state.”
Orman, an Olathe businessman who is challenging U.S. Sen. Pat Roberts, is a defendant in a separate lawsuit for $30 million brought by the boxing equipment manufacturer Everlast, which is set to go to trial in October 2015.